![Rasha Aboelhassan: Presenting updated NCCN Guidelines for epithelial ovarian cancer to a group of professionals and young oncologists was a rewarding experience](https://oncodaily.com/pub/uploads/2024/02/1709100298655-1280x960.jpeg)
Photo taken from: Rasha Aboelhassan/LinkedIn
Feb 29, 2024, 14:42
Rasha Aboelhassan: Presenting updated NCCN Guidelines for epithelial ovarian cancer to a group of professionals and young oncologists was a rewarding experience
Rasha Aboelhassan,
Nasser Institute Hospital, shared on LinkedIn:“Presenting updated NCCN Guidelines for epithelial ovarian cancer to a group of professionals and young oncologists was a rewarding experience.
During the voting session, they changed their minds from voting 3 to voting 7 when they discussed the updates of PARP INHIBITORS that changed the Guidelines.
It was amazing to witness the impact of new information on decision-making.
The feeling of satisfaction is unparalleled.
thanks for all GSK team and Dr. Nagah Saleh from Egypt Airlines Hospital”
Source: Rasha Aboelhassan/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023